Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia
- PMID: 15034828
- DOI: 10.1086/382362
Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia
Abstract
The purified protein derivative (PPD) skin test for Mycobacterium tuberculosis infection lacks specificity. We assessed 2 more specific M. tuberculosis antigens (ESAT-6 and CFP-10) by enzyme-linked immunospot assay (ELISPOT) compared with PPD by ELISPOT and skin test in The Gambia. Of 735 household contacts of 130 sputum smear-positive tuberculosis cases, 476 (65%) tested positive by PPD ELISPOT, 300 (41%) tested positive by PPD skin test, and 218 (30%) tested positive by ESAT-6/CFP-10 ELISPOT. Only 15 (2%) had positive ESAT-6/CFP-10 results and negative PPD results by ELISPOT. With increasing M. tuberculosis exposure, the percentage of subjects who were PPD skin test positive/ESAT-6/CFP-10 ELISPOT negative increased (P<.001), whereas the percentage of subjects who were PPD skin test negative/PPD ELISPOT positive decreased (P=.011). Eighteen (31%) ESAT-6/CFP-10 ELISPOT-positive subjects in the lowest exposure category had negative PPD skin test results. ESAT-6/CFP-10 ELISPOT probably offers increased specificity in the diagnosis of M. tuberculosis infection in this tropical setting of endemicity, at the cost of some sensitivity.
Similar articles
-
Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The Gambia.PLoS One. 2006 Dec 20;1(1):e68. doi: 10.1371/journal.pone.0000068. PLoS One. 2006. PMID: 17183699 Free PMC article.
-
Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model.Clin Infect Dis. 2005 Jan 15;40(2):273-8. doi: 10.1086/427030. Epub 2004 Dec 20. Clin Infect Dis. 2005. PMID: 15655747
-
ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the Gambia.J Clin Microbiol. 2005 May;43(5):2070-4. doi: 10.1128/JCM.43.5.2070-2074.2005. J Clin Microbiol. 2005. PMID: 15872224 Free PMC article.
-
[Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].Kekkaku. 2006 Nov;81(11):681-6. Kekkaku. 2006. PMID: 17154047 Review. Japanese.
-
[Evolution of IGRA researches].Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
Cited by
-
An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.J Clin Microbiol. 2006 Jun;44(6):1944-50. doi: 10.1128/JCM.02265-05. J Clin Microbiol. 2006. PMID: 16757583 Free PMC article.
-
Risk factors for pulmonary tuberculosis: a clinic-based case control study in The Gambia.BMC Public Health. 2006 Jun 19;6:156. doi: 10.1186/1471-2458-6-156. BMC Public Health. 2006. PMID: 16784521 Free PMC article.
-
Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda.Am J Trop Med Hyg. 2006 Jul;75(1):55-61. Am J Trop Med Hyg. 2006. PMID: 16837709 Free PMC article.
-
Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases.BMC Infect Dis. 2006 Mar 30;6:66. doi: 10.1186/1471-2334-6-66. BMC Infect Dis. 2006. PMID: 16573826 Free PMC article.
-
Immunogenicity of antigens from the TbD1 region present in M. africanum and missing from "modern" M. tuberculosis: a cross- sectional study.BMC Infect Dis. 2010 Jan 19;10:11. doi: 10.1186/1471-2334-10-11. BMC Infect Dis. 2010. PMID: 20085647 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous